Administration of zidovudine during primary HIV-1 infection may be associated with a less vigorous immune response.
Tindall
B
B
Carr
A
A
Goldstein
D
D
Penny
R
R
Cooper
D A
DA
D016827:CD8 Antigens; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology; D015497:HIV-1; D006801:Humans; D007107:Immune System / Q000187:drug effects; D008297:Male; D016176:T-Lymphocyte Subsets / Q000187:drug effects / Q000276:immunology; D015215:Zidovudine / Q000009:adverse effects*
D016827:CD8 Antigens; D015215:Zidovudine